ストックスクリーナーアプリを入手
6.78
1.04%
0.07
アフターアワーズ：
6.78
前日終値:
$6.71
開ける：
$6.76
24時間の取引高:
6.46M
Relative Volume:
1.31
時価総額：
$1.76B
収益：
$6.28B
当期純損益:
$700.00M
株価収益率:
2.5184
EPS:
2.6922
ネットキャッシュフロー:
$537.00M
1週間 パフォーマンス:
+0.44%
1か月 パフォーマンス:
-36.04%
6か月 パフォーマンス:
-22.60%
1年 パフォーマンス:
-57.94%
1日の値動き範囲:
$6.445
$6.80
1週間の範囲:
$6.33
$6.855
52週間の値動き範囲:
$6.18
$17.23
Organon Co Stock (OGN) Company Profile
OGN を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
OGN
Organon Co
|
6.78 | 1.74B | 6.28B | 700.00M | 537.00M | 2.6922 |
|
LLY
Lilly Eli Co
|
924.37 | 839.03B | 59.42B | 18.41B | 6.44B | 20.22 |
|
JNJ
Johnson Johnson
|
186.57 | 450.47B | 92.15B | 25.12B | 20.46B | 10.36 |
|
ABBV
Abbvie Inc
|
219.16 | 387.13B | 59.64B | 2.36B | 18.24B | 1.3253 |
|
NVS
Novartis Ag Adr
|
126.35 | 242.86B | 54.45B | 14.42B | 17.15B | 7.333 |
|
MRK
Merck Co Inc
|
86.28 | 212.91B | 63.99B | 19.05B | 14.72B | 7.5596 |
Organon Co Stock (OGN) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-10-27 | ダウングレード | Piper Sandler | Overweight → Underweight |
| 2025-05-02 | ダウングレード | Evercore ISI | Outperform → In-line |
| 2024-09-06 | ダウングレード | JP Morgan | Neutral → Underweight |
| 2023-11-03 | ダウングレード | Goldman | Buy → Neutral |
| 2023-09-21 | 開始されました | Barclays | Overweight |
| 2023-03-16 | 開始されました | Raymond James | Outperform |
| 2022-10-14 | ダウングレード | BofA Securities | Neutral → Underperform |
| 2022-09-06 | アップグレード | Piper Sandler | Neutral → Overweight |
| 2022-08-05 | ダウングレード | BofA Securities | Buy → Neutral |
| 2022-04-27 | 開始されました | Goldman | Buy |
| 2022-04-06 | 再開されました | Morgan Stanley | Equal-Weight |
| 2021-10-07 | 開始されました | Piper Sandler | Neutral |
| 2021-09-01 | 開始されました | BofA Securities | Buy |
| 2021-07-22 | 開始されました | Citigroup | Buy |
| 2021-06-15 | 開始されました | JP Morgan | Neutral |
| 2021-06-11 | 開始されました | Morgan Stanley | Equal-Weight |
| 2021-06-10 | 開始されました | Evercore ISI | Outperform |
すべてを表示
Organon Co (OGN) 最新ニュース
Organon announces agreement to divest its JADA System for up to $465M to Laborie - ROI-NJ
Organon & Co expected to post earnings of 94 cents a shareEarnings Preview - TradingView
Organon to divest Jada System for up to $465M to Laborie - TipRanks
Laborie to Buy Specialist Medical Device For Up To $465 Million From Organon - MarketScreener
Organon rises after agreeing to sell postpartum bleeding device to Laborie for up to $465 mln - TradingView
Grace Puma to Step Down from Organon Board - TipRanks
Organon director Grace Puma to step down after 2026 annual meeting - Investing.com
Organon to sell JADA System to Laborie for up to $465 million By Investing.com - Investing.com Canada
Organon announces agreement to divest its Jada system for up to $465 million to Laborie - MarketScreener
Organon & Co. Announces Board Member Departure - TradingView
Laborie Announces Agreement to Acquire the JADA® System from Organon - Yahoo Finance
Investors Give Organon & Co. (NYSE:OGN) Shares A 41% Hiding - simplywall.st
Organon To Report Third Quarter 2025 Results and Host Conference Call on November 10, 2025 - Business Wire
Co. (7XP) stock profit from automation waveJuly 2025 Spike Watch & Growth Focused Stock Reports - newser.com
Organon Stock Tumbles To Record Low On Downgrades And Dividend Cut: Retail Optimism Persists - MSN
Bryce Point Capital LLC Purchases Shares of 48,068 Organon & Co. $OGN - MarketBeat
Co. (7XP) stockTrade Signal Summary & Real-Time Volume Triggers - newser.com
L’Association canadienne pour l’équité en santé des femmes et ses partenaires réclament un investissement audacieux dans la santé des femmes afin de combler définitivement les inégalités - GlobeNewswire Inc.
Aviance Capital Partners LLC Takes $599,000 Position in Organon & Co. $OGN - MarketBeat
Institutional Investors May Adopt Severe Steps After Organon & Co.'s (NYSE:OGN) Latest 26% Drop Adds to a Year Losses - 富途牛牛
Organon & Co. $OGN Holdings Cut by Fisher Funds Management LTD - MarketBeat
Organon & Co. Stock Plummets to New 52-Week Low of $6.18 - Markets Mojo
Co. (7XP) stock survive global slowdownQuarterly Risk Review & Real-Time Chart Pattern Alerts - newser.com
Jim Cramer’s “Worst Stock Ever” Might Be Organon (OGN) - MSN
Organon & Co. (OGN) Analyst insights, Price targets and Recommendations - Yahoo! Finance UK
KLCM Advisors Inc. Decreases Stake in Organon & Co. $OGN - MarketBeat
Crisis at Organon: Leadership Ousted Amid Sales Scandal - AD HOC NEWS
Tangible book value per share of Organon & Co. – BMV:OGN - TradingView
OGN 8-K/A discloses interim Executive Chair compensation terms - Stock Titan
The Vanguard Group files 13G/A for Organon with 13.82% stake - Stock Titan
Organon & Co. Common Stock (NY: OGN - FinancialContent
Organon stock plunges as CEO resigns amid Nexplanon sales probe - MSN
The Escalator: Organon, Kenvue, Real Chemistry and more - Medical Marketing and Media
Organon & Co. $OGN Shares Acquired by State of New Jersey Common Pension Fund D - MarketBeat
Co. (7XP) stock in 20252025 Sector Review & Safe Entry Point Alerts - newser.com
Organon & Co. (OGN) Stock forecasts - Yahoo! Finance UK
Organon & Co. (OGN) Stock Forecasts - Yahoo! Finance Canada
Organon (OGN) Price Target Decreased by 15.36% to 11.05 - Nasdaq
Organon & Co. (NYSE:OGN) Given Average Rating of "Hold" by Brokerages - MarketBeat
Organon: Critical Assessment Of The Audit Committee Investigation Results (NYSE:OGN) - Seeking Alpha
Organon & Co. (NYSE:OGN) Shares Down 6.2% Following Analyst Downgrade - MarketBeat
Organon Looks For New CEO Amid Investigation Into Front-Loading Contraceptive Implant Sales - Citeline News & Insights
Organon (OGN) Is Down 26.2% After CEO Resignation and Audit Reveals Sales Practice Issues – What's Changed - simplywall.st
Peregrine Capital Management LLC Increases Stock Position in Organon & Co. $OGN - MarketBeat
D.A. Davidson & CO. Sells 50,248 Shares of Organon & Co. $OGN - MarketBeat
Why Organon (OGN) Stock Is Down Today - Yahoo Finance
Organon’s Stock Tumbles Amidst Leadership Shake-Up - StocksToTrade
Organon hit hard over ousted CEO scandal - The Pharma Letter
The Bottom Fishing ClubOrganon: Deep Value In Drugs/Medical Products (NYSE:OGN) - Seeking Alpha
Organon & Co. (NYSE:OGN) Hits New 52-Week Low After Analyst Downgrade - MarketBeat
Organon Investigation Initiated By Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates Claims On Behalf of Investors of Organon & Co.OGN - MarketScreener
Organon Co (OGN) 財務データ
収益
当期純利益
現金流量
EPS
Organon Co (OGN) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| Arjona Ferreira Juan Camilo | Head of R&D & CMO |
Aug 11 '25 |
Option Exercise |
0.00 |
11,519 |
0 |
28,899 |
| COX CARRIE SMITH | Director |
May 14 '25 |
Buy |
8.07 |
12,469 |
100,591 |
12,469 |
| Falcione Aaron | Chief Human Resources Officer |
May 07 '25 |
Buy |
8.77 |
5,500 |
48,235 |
62,974 |
| Weaver Kirke | Gen. Counsel & Corp. Secy. |
May 06 '25 |
Buy |
9.21 |
8,045 |
74,054 |
52,489 |
| Karp Daniel | Executive VP, Corp. Dev. |
May 06 '25 |
Buy |
8.24 |
3,500 |
28,828 |
46,669 |
| WALSH MATTHEW M | Chief Financial Officer |
May 05 '25 |
Buy |
8.82 |
11,400 |
100,548 |
144,484 |
| Ali Kevin | Chief Executive Officer |
May 05 '25 |
Buy |
8.80 |
34,000 |
299,370 |
282,731 |
| Falcione Aaron | Chief Human Resources Officer |
Mar 31 '25 |
Option Exercise |
0.00 |
18,732 |
0 |
59,237 |
| Karp Daniel | Executive VP, Corp. Dev. |
Mar 31 '25 |
Option Exercise |
0.00 |
34,677 |
0 |
44,515 |
| Stahler Rachel A | Chief Information Officer |
Mar 31 '25 |
Option Exercise |
0.00 |
18,334 |
0 |
78,994 |
0.34%
1.69%
大文字化:
|
ボリューム (24 時間):